People: Entera Bio Ltd (ENTX.OQ)
13 Nov 2019
Dr. Roger J. Garceau is Director of the company since March 2016 and as Chief Development Advisor since December 2016. Prior to joining Entera, Dr. Garceau served as Chief Medical Officer and Executive Vice President of NPS Pharmaceuticals, Inc. since December 2008 and January 2013 respectively, until February 2015, when NPS Pharmaceuticals was acquired by Shire plc. Previously, Dr. Garceau served in several managerial positions with NPS Pharmaceuticals, Inc. Sanofi-aventis and Pharmacia Corporation. Dr. Garceau has been a non-executive director of Enterome SA since December 2016. Dr. Garceau is a board-certified pediatrician and is a Fellow of the American Academy of Pediatrics. Dr. Garceau holds a B.S. in Biology from Fairfield University in Fairfield, Connecticut and an M.D. from the University of Massachusetts Medical School.
|Total Annual Compensation, USD||--|
|Restricted Stock Award, USD||886,925|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||114,000|
|Fiscal Year Total, USD||1,000,920|